Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) Equity Ratio (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Equity Ratio for 3 consecutive years, with 0.51 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 40.09% to 0.51 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.51, a 40.09% decrease, with the full-year FY2025 number at 0.51, down 40.09% from a year prior.
  • Equity Ratio was 0.51 for Q4 2025 at Nuvation Bio, down from 0.54 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.98 in Q1 2023 to a low of 0.43 in Q2 2024.
  • A 3-year average of 0.79 and a median of 0.87 in 2024 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: tumbled 55.6% in 2024, then soared 33.25% in 2025.
  • Nuvation Bio's Equity Ratio stood at 0.97 in 2023, then decreased by 11.89% to 0.86 in 2024, then plummeted by 40.09% to 0.51 in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Equity Ratio are 0.51 (Q4 2025), 0.54 (Q3 2025), and 0.58 (Q2 2025).